Fintel reports that on November 11, 2024, Piper Sandler downgraded their outlook for Xeris Biopharma Holdings ...

Piper Sandler analyst Harsh Kumar raised the firm’s price target on Nvidia (NVDA) to $175 from $140 and keeps an Overweight rating on the ...

The numbers: Block shares were up 10.5% to $126.19 by 12:15pm AEDT. The context: The climb followed a bullish analyst note by ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As previously reported, Piper Sandler downgraded ProAssurance (PRA) to Neutral from Overweight with a $18 price target The firm believes the stock is no longer as undervalued as it once was based ...

Investing.com - Nvidia (NASDAQ:NVDA) is "well-positioned" to capture most of the expected growth in the market for specialized artificial intelligence-enhancing hardware in 2025, analysts at Piper ...

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for ...

Under Trump, bank deal approvals are likely to “speed up markedly and the process will be more clearly delineated,” one ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm, has demonstrated resilience and strategic growth in a dynamic financial landscape. The company's ...

Celanese (NYSE:CE) -4.7% in Friday's trading to its lowest in more than four years after Piper Sandler downgrades shares to ...